Respiratory Monitoring Devices Market is Anticipated to Grow at A Sluggish CAGR of 6.3% by 2031- TMR Study

The global respiratory monitoring devices market has witnessed substantial growth, valuing at US$ 7.7 billion in 2021 and projected to exceed US$ 15 billion by 2031, marking a steady CAGR of 6.3%. The surge in demand for respiratory monitoring devices has been primarily fueled by the critical role they play in addressing respiratory ailments, particularly during the COVID-19 pandemic. These devices have become integral in healthcare facilities and homes, monitoring and managing respiratory conditions among patients.

The Role of Respiratory Monitoring Devices

Respiratory monitoring devices encompass an array of tools, from smart pulse oximeters to spirometers, aiding in the evaluation and management of various respiratory conditions like acute respiratory failure, chronic obstructive pulmonary disease (COPD), and asthma. Their importance extends across personal use, intensive care, and in-patient settings.

Request for a sample of this research report at (Use Corporate Mail Id for Quick Response) - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1415&utm_source=OpenPR_Ganesh&utm_medium=OpenPR

Key Players and Innovations

The market's competitive landscape sees major players such as Medtronic, Philips Healthcare, Smiths Medical, and Masimo investing in product innovations and technological advancements. For instance, Medtronic expanded its remote respiratory monitoring solutions during the COVID-19 outbreak, while Masimo received FDA approval for its finger pulse oximeter, MightSat Rx, enhancing its share in the market.

Medtronic, Philips Healthcare (Koninklijke Philips N.V.), Smiths Medical (part of Smiths Group plc), Dragerwerk AG & Co. KGaA, GE Healthcare (part of General Electric Company), and Welch Allyn, Inc. (Hill-Rom Holdings, Inc.)

Drivers of Market Growth

The escalation in respiratory diseases like asthma, cystic fibrosis, and COPD, coupled with the prevalence of obstructive sleep apnea, has propelled the demand for respiratory monitoring devices. Around 65 million individuals globally struggle with COPD, while approximately 25 million contend with sleep apnea, emphasizing the critical need for advanced monitoring solutions.

Moreover, the rise in the elderly population, characterized by weakened immune systems and increased vulnerability to respiratory diseases, has significantly contributed to the market's growth. The geriatric demographic, expected to surge in both developed and developing countries, signifies a higher demand for therapeutic respiratory devices.

Product Segments and End-User Landscape

The market segments are diverse, ranging from pulse oximeters, capnographs, and spirometers to gas analyzers and polysomnographs (PSG). Among these, pulse oximeters lead the market with a dominant 37% share in 2021, attributing their success to technological advancements offering non-invasive and painless tests for oxygen saturation levels.

In terms of end-users, hospitals hold the largest share, around 39% in 2021, owing to the easy accessibility of respiratory devices, the growing patient population, and an increased demand for monitoring devices.

Regional Dynamics

North America spearheaded the market in 2021, securing a significant 36% share, driven by FDA approvals and established companies offering respiratory care devices. Meanwhile, Europe and Asia Pacific exhibited substantial shares in 2021, with Europe showing rapid growth due to intensified focus on respiratory care management in home care settings.

Buy this Premium Research Report | Immediate Delivery Available at - https://www.transparencymarketresearch.com/checkout.php?rep_id=1415<ype=S&utm_source=OpenPR_Ganesh&utm_medium=OpenPR

The global respiratory monitoring devices market continues its growth trajectory, powered by the imperative need to manage and monitor respiratory conditions, especially in the wake of the COVID-19 pandemic. Technological advancements, increasing prevalence of respiratory diseases, and the rising elderly population globally underscore the criticality of these monitoring devices.

As key players continue to innovate and expand their product portfolios, the market is set for further expansion, with a focus on providing efficient, non-invasive, and accessible solutions for respiratory monitoring across diverse demographics and healthcare settings.

About Us Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

Contact Us

Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

This release was published on openPR.